Question to the Department of Health and Social Care:

To ask Her Majesty's Government how many people in England they estimate are currently addicted to prescription opioids, excluding cancer patients.

Information on the number of people in England currently addicted to prescription opioids is not collected centrally. The Government is concerned about the impact of long term use of prescription drugs. The Department has commissioned Public Health England (PHE) to undertake an evidence review to better understand the scope of the problem of prescribed drug dependence.

The review will bring together the best available evidence on prevalence and prescribing; the nature and likely causes of dependence or discontinuation syndrome among some people who continue to take these medicines; and effective prevention and treatment responses for each condition for which they are prescribed. There are no plans to extend the remit of the PHE evidence review to over the counter painkillers.

The National Institute for Health and Care Excellence (NICE) published the guideline Controlled drugs: safe use and management in April 2016 which covers systems and processes for using and managing controlled drugs safely in all NHS settings except care homes. The guideline includes recommendations to improve working practices to comply with legislation and aims to reduce the risks associated with controlled drugs, including dependency, overdose and diversion. The NICE guideline provides authoritative guidance that reflects the latest available evidence and will allow healthcare professionals, including general practitioners, to make informed decisions about the prescription and optimal use of medicines which have the potential to cause dependency. A copy of the NICE guideline is attached.

The recently-updated national clinical guidelines for drug misuse and dependence have specific guidance about pharmacological management of dependence on benzodiazepines and z-drugs, including prescribing regimens, detoxification, adjunctive therapies and monitoring. A copy of these guidelines, Drugs misuse and dependence: UK guidelines on clinical management is attached.